A deficiency of apoptosis inducing factor (AIF) in Harlequin mouse heart mitochondria paradoxically reduces ROS generation during ischemia-reperfusion

Frontiers in Physiology

Volumn 5 JUN, Issue , 2014, Pages

  Chen, Qun ^a   Szczepanek, Karol ^a   Hu, Ying ^a   Thompson, Jeremy ^a   Lesnefsky, Edward J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Electron transport chain; Poly(ADP ribose); Reactive oxygen species

Indexed keywords

APOPTOSIS INDUCING FACTOR; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN LOCALIZATION;

EID: 84904395583     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00271     Document Type: Article

References (54)

1. S. K. Natarajan and D. F. Becker: Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress. Cell Health Cytoskelet, 2012(4), 11-27 (2012)
2. I. F. Sevrioukova: Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal, 14(12), 2545-79 (2011)
3. J. A. Klein, C. M. Longo-Guess, M. P. Rossmann, K. L. Seburn, R. E. Hurd, W. N. Frankel, R. T. Bronson and S. L. Ackerman: The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature, 419(6905), 367-74 (2002)
4. V. P. van Empel, A. T. Bertrand, R. van der Nagel, S. Kostin, P. A. Doevendans, H. J. Crijns, E. de Wit, W. Sluiter, S. L. Ackerman and L. J. De Windt: Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res, 96(12), e92-e101 (2005)
5. N. Vahsen, C. Cande, J. J. Briere, P. Benit, N. Joza, N. Larochette, P. G. Mastroberardino, M. O. Pequignot, N. Casares, V. Lazar, O. Feraud, N. Debili, S. Wissing, S. Engelhardt, F. Madeo, M. Piacentini, J. M. Penninger, H. Schagger, P. Rustin and G. Kroemer: AIF deficiency compromises oxidative phosphorylation. Embo J, 23(23), 4679-89 (2004)
6. N. Joza, G. Y. Oudit, D. Brown, P. Benit, Z. Kassiri, N. Vahsen, L. Benoit, M. M. Patel, K. Nowikovsky, A. Vassault, P. H. Backx, T. Wada, G. Kroemer, P. Rustin and J. M. Penninger: Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol, 25(23), 10261-72 (2005)
7. J. A. Pospisilik, C. Knauf, N. Joza, P. Benit, M. Orthofer, P. D. Cani, I. Ebersberger, T. Nakashima, R. Sarao, G. Neely, H. Esterbauer, A. Kozlov, C. R. Kahn, G. Kroemer, P. Rustin, R. Burcelin and J. M. Penninger: Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell, 131(3), 476-91 (2007)
8. E. M. Oxler, A. Dolga and C. Culmsee: AIF depletion provides neuroprotection through a preconditioning effect. Apoptosis, 17(10), 1027-38 (2012)
9. Q. Chen, A. K. Camara, D. F. Stowe, C. L. Hoppel and E. J. Lesnefsky: Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol, 292(1), C137-47 (2007)
10. T. Hisatomi, T. Sakamoto, T. Murata, I. Yamanaka, Y. Oshima, Y. Hata, T. Ishibashi, H. Inomata, S. A. Susin and G. Kroemer: Relocalization of apoptosis-inducing factor in photoreceptor apoptosis induced by retinal detachment in vivo. Am J Pathol, 158(4), 1271-8 (2001)
11. S. J. Chinta, A. Rane, N. Yadava, J. K. Andersen, D. G. Nicholls and B. M. Polster: Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria. Free Radic Biol Med, 46(7), 939-47 (2009)
12. A. B. Gustafsson and R. A. Gottlieb: Heart mitochondria: gates of life and death. Cardiovasc Res, 77(2), 334-43 (2008)
13. E. J. Lesnefsky, S. Moghaddas, B. Tandler, J. Kerner and C. L. Hoppel: Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol, 33(6), 1065-89 (2001)
14. E. Murphy and C. Steenbergen: Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev, 88(2), 581-609 (2008)
15. J. F. Turrens: Mitochondrial formation of reactive oxygen species. J Physiol, 552(Pt 2), 335-44 (2003)
16. P. Wenzel, S. Schuhmacher, J. Kienhofer, J. Muller, M. Hortmann, M. Oelze, E. Schulz, N. Treiber, T. Kawamoto, K. Scharffetter-Kochanek, T. Munzel, A. Burkle, M. M. Bachschmid and A. Daiber: Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate agedependent vascular dysfunction. Cardiovasc Res, 80(2), 280-9 (2008)
17. J. F. Turrens, M. Beconi, J. Barilla, U. B. Chavez and J. M. McCord: Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun, 12-13(Pt 2), 681-9. (1991)
18. B. A. Stanley, V. Sivakumaran, S. Shi, I. McDonald, D. Lloyd, W. H. Watson, M. A. Aon and N. Paolocci: Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria. J Biol Chem, 286(38), 33669-77 (2011)
19. M. P. Rigobello, F. Vianello, A. Folda, C. Roman, G. Scutari and A. Bindoli: Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase. Biochem Biophys Res Commun, 343(3), 873-8 (2006)
20. S. W. Yu, H. Wang, M. F. Poitras, C. Coombs, W. J. Bowers, H. J. Federoff, G. G. Poirier, T. M. Dawson and V. L. Dawson: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297(5579), 259-63 (2002)
21. Q. Chen, M. Paillard, L. Gomez, T. Ross, Y. Hu, A. Xu and E. J. Lesnefsky: Activation of mitochondrial mu-calpain increases AIF cleavage in cardiac mitochondria during ischemia-reperfusion. Biochem Biophys Res Commun, 415(4), 533-8 (2011)
22. T. Ozaki, H. Tomita, M. Tamai and S. Ishiguro: Characteristics of mitochondrial calpains. J Biochem, 142(3), 365-76 (2007)
23. M. Yuan, C. Siegel, Z. Zeng, J. Li, F. Liu and L. D. McCullough: Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol, 217(1), 210-8 (2009)
24. Q. Chen, S. Moghaddas, C. L. Hoppel and E. J. Lesnefsky: Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther, 319(3), 1405-12 (2006)
25. E. J. Lesnefsky, B. Tandler, J. Ye, T. J. Slabe, J. Turkaly and C. L. Hoppel: Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol, 273(3 Pt 2), H1544-54. (1997)
26. Q. Chen, S. Moghaddas, C. L. Hoppel and E. J. Lesnefsky: Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol, 294(2), C460-6 (2008)
27. S. Krahenbuhl, M. Chang, E. P. Brass and C. L. Hoppel: Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[clactam]- induced methylmalonic aciduria. J Biol Chem, 266(31), 20998-1003 (1991)
28. Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel and E. J. Lesnefsky: Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem, 278, 36027-36031 (2003)
29. Q. Chen, M. Paillard, L. Gomez, H. Li, Y. Hu and E. J. Lesnefsky: Postconditioning modulates ischemia-damaged mitochondria during reperfusion. J Cardiovasc Pharmacol, 59(1), 101-8 (2012)
30. K. Szczepanek, Q. Chen, M. Derecka, F. N. Salloum, Q. Zhang, M. Szelag, J. Cichy, R. C. Kukreja, J. Dulak, E. J. Lesnefsky and A. C. Larner: Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemiainduced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem, 286(34), 29610-20 (2011)
31. W. Rouslin and R. W. Millard: Canine myocardial ischemia: defect in mitochondrial electron transfer complex I. J Mol Cell Cardiol, 12(6), 639-45 (1980)
32. W. Rouslin: Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol, 244(6), H743-8. (1983)
33. H. Z. Zhou, R. A. Swanson, U. Simonis, X. Ma, G. Cecchini and M. O. Gray: Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Am J Physiol Heart Circ Physiol, 291(2), H714-23 (2006)
34. T. Ohnishi and B. L. Trumpower: Differential effects of antimycin on ubisemiquinone bound in different environments in isolated succinate. cytochrome c reductase complex. J Biol Chem, 255(8), 3278-84. (1980)
35. L. S. Burwell, S. M. Nadtochiy, A. J. Tompkins, S. Young and P. S. Brookes: Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J, 394(Pt 3), 627-34 (2006)
36. T. R. Hurd, R. Requejo, A. Filipovska, S. Brown, T. A. Prime, A. J. Robinson, I. M. Fearnley and M. P. Murphy: Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage. J Biol Chem, 283(36), 24801-15 (2008)
37. G. Paradies, G. Petrosillo, M. Pistolese, N. Di Venosa, A. Federici and F. M. Ruggiero: Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res, 94(1), 53-9 (2004)
38. K. Szczepanek, Y. Hu, E. J. Lesnefsky and Q. Chen: Deficiency of Apoptosis inducing factor (AIF) decreases complex I activity and increases the ROS generation in isolated cardiac mitochondria. Faseb J, 27, 1085.18 (abstract) (2013)
39. M. N. Rossi, M. Carbone, C. Mostocotto, C. Mancone, M. Tripodi, R. Maione and P. Amati: Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem, 284(46), 31616-24 (2009)
40. A. Xu, K. Szczepanek, M. W. Maceyka, T. Ross, E. Bowler, Y. Hu, B. Kenny, C. Mehfoud, P. N. Desai, C. M. Baumgarten, Q. Chen and E. J. Lesnefsky: Transient complex I inhibition at the onset of reperfusion by extracellular acidification decreases cardiac injury. Am J Physiol Cell Physiol, 306(12), C1142-53 (2014)
41. Q. Chen, T. Ross, Y. Hu and E. J. Lesnefsky: Blockade of electron transport at the onset of reperfusion decreases cardiac injury in aged hearts by protecting the inner mitochondrial membrane. J Aging Res, 2012, 753949 (2012)
42. S. Stewart, E. J. Lesnefsky and Q. Chen: Reversible blockade of electron transport with amobarbital at the onset of reperfusion attenuates cardiac injury. Transl Res, 153(5), 224-31 (2009)
43. G. Karamanlidis, C. F. Lee, L. Garcia-Menendez, S. C. Kolwicz, Jr., W. Suthammarak, G. Gong, M. M. Sedensky, P. G. Morgan, W. Wang and R. Tian: Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab, 18(2), 239-50 (2013)
44. J. Horstkotte, T. Perisic, M. Schneider, P. Lange, M. Schroeder, C. Kiermayer, R. Hinkel, T. Ziegler, P. K. Mandal, R. David, S. Schulz, S. Schmitt, J. Widder, F. Sinowatz, B. F. Becker, J. Bauersachs, M. Naebauer, W. M. Franz, I. Jeremias, M. Brielmeier, H. Zischka, M. Conrad and C. Kupatt: Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection. Circulation, 124(25), 2892-902 (2011)
45. E. Norberg, V. Gogvadze, H. Vakifahmetoglu, S. Orrenius and B. Zhivotovsky: Oxidative modification sensitizes mitochondrial apoptosis-inducing factor to calpainmediated processing. Free Radic Biol Med, 48(6), 791-7 (2010)
46. H. Otera, S. Ohsakaya, Z. Nagaura, N. Ishihara and K. Mihara: Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. Embo J, 24(7), 1375-86 (2005)
47. L. Cabon, P. Galan-Malo, A. Bouharrour, L. Delavallee, M. N. Brunelle-Navas, H. K. Lorenzo, A. Gross and S. A. Susin: BID regulates AIF-mediated caspaseindependent necroptosis by promoting BAX activation. Cell Death Differ, 19(2), 245-56 (2012)
48. J. N. Weiss, P. Korge, H. M. Honda and P. Ping: Role of the mitochondrial permeability transition in myocardial disease. Circ Res, 93(4), 292-301. (2003)
49. A. P. Halestrap, S. J. Clarke and S. A. Javadov: Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res, 61(3), 372-85 (2004)
50. J. M. Schriewer, C. B. Peek, J. Bass and P. T. Schumacker: ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J Am Heart Assoc, 2(2), e000159 (2013)
51. P. Pacher and C. Szabo: Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev, 25(3), 235-60 (2007)
52. S. W. Yu, S. A. Andrabi, H. Wang, N. S. Kim, G. G. Poirier, T. M. Dawson and V. L. Dawson: Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymerinduced cell death. Proc Natl Acad Sci U S A, 103(48), 18314-9 (2006)
53. S. W. Yu, Y. Wang, D. S. Frydenlund, O. P. Ottersen, V. L. Dawson and T. M. Dawson: Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release. ASN Neuro, 1(5) (2009)
54. Y. Wang, N. S. Kim, X. Li, P. A. Greer, R. C. Koehler, V. L. Dawson and T. M. Dawson: Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos). J Neurochem, 110(2), 687-96 (2009)